BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25201958)

  • 1. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.
    Königer C; Wingert I; Marsmann M; Rösler C; Beck J; Nassal M
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4244-53. PubMed ID: 25201958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?
    Cui X; McAllister R; Boregowda R; Sohn JA; Cortes Ledesma F; Caldecott KW; Seeger C; Hu J
    PLoS One; 2015; 10(6):e0128401. PubMed ID: 26079492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Luo J; Luckenbaugh L; Hu H; Yan Z; Gao L; Hu J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.
    Köck J; Rösler C; Zhang JJ; Blum HE; Nassal M; Thoma C
    PLoS Pathog; 2010 Sep; 6(9):e1001082. PubMed ID: 20824087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
    Xi J; Cui X; Liu K; Liu H; Wang J; Hu J
    J Virol; 2022 Apr; 96(8):e0039922. PubMed ID: 35389266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
    Nassal M
    Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
    Schreiner S; Nassal M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
    Tang L; Sheraz M; McGrane M; Chang J; Guo JT
    PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
    Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
    J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein.
    Gao W; Hu J
    J Virol; 2007 Jun; 81(12):6164-74. PubMed ID: 17409153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
    Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
    Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
    PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.